Featured Research

from universities, journals, and other organizations

Gene Variant May Hasten Silent Strokes, Debilitating Stroke Or Alzheimer's

Date:
February 9, 1999
Source:
American Heart Association
Summary:
For several years, scientists have known that people who have inherited the E-4 variant of the apolipoprotein (apo) gene are at high risk for developing Alzheimers disease. Now they say that having the gene may also signal a higher likelihood of having stroke or another vascular disease in the brain.

NASHVILLE, Feb. 6 -- For several years, scientists have known that people who have inherited the E-4 variant of the apolipoprotein (apo) gene are at high risk for developing Alzheimers disease. Now they say that having the gene may also signal a higher likelihood of having stroke or another vascular disease in the brain.

The study's lead scientist, Charles DeCarli, M.D., says that people who have the apoE-4 gene variant and high blood pressure have smaller brain volumes and more abnormal white matter in the brain and thus may be more susceptible to silent strokes, which take a toll over time.

The research findings were presented here today at the 24th American Heart Association International Conference on Stroke and Cerebral Circulation.

Not only do the brain changes lead to a gradual deterioration of memory and motor skills, they also may place the person at risk for Alzheimer's disease, he says.

"When you go swimming, you wear a bathing suit instead of pants so that you wont be weighed down when you get in the water," explains DeCarli, of the University of Kansas Medical Center, Kansas City, Kan. "By the same token, a smaller brain volume, excess white matter abnormalities or silent stroke, can weigh you down and make you more susceptible to the effects of early Alzheimer's disease."

DeCarli says people who have the apoE-4 gene variant and high blood pressure or other vascular risk factors are at particularly high risk of having a stroke. Vascular disease affects the blood vessels in the brain, says DeCarli.

"People who do not have vascular disease and apoE-4 are not harmed, but if you have high blood pressure or other vascular disease and this apoE-4 gene allele, it really hurts your brain," says DeCarli. "It sets you up for some cognitive impairment. It reinforces the genetic risk for brain injury related to hypertension and vascular disease as you age."

Researchers are not sure how apoE-4 affects the brain, but DeCarli notes, "The apoE-4 may impair brain recovery from injury of any type, whether its Alzheimers or other vascular disease or head trauma. Having apoE-4, therefore, may increase ones chances of a poor outcome following any brain injury."

Scientists studied 414 men participating in the National Heart, Lung, and Blood Institutes Twin Study. Researchers used magnetic resonance imaging (MRI) to determine the study participants who had silent strokes, abnormalities in the white matter of the brain -- called white matter hyperintensities -- or smaller brains.

"The difference between using MRI and not using MRI to measure the amount of brain is significant," says DeCarli. "With MRI, you're going to catch more of the strokes and white matter disease. We can get a better idea of whats going on in the brain."

In silent strokes, people don't have any of the classic warning signs such as sudden headaches, dizziness or loss of motor skills. Silent strokes occur when smaller blood vessels in the brain are blocked or rupture. Silent strokes arent as damaging, at least initially, as strokes that occur when the carotid arteries in the neck are blocked or burst.

But silent strokes do take their toll over time. When the smaller vessels are unable to deliver oxygen and blood to the brain, cells die. Over time, brain cells that control functions such as memory and motor skills die off, leading to difficulty in memory, concentration and even walking. The researchers do not recommend screening people for apoE-4.

"This is one part of the bigger picture that needs to be examined further," says DeCarli. "It may be worth testing people for risk factors and controlling those rather than seeing if they have the apoE-4 or not."

The average age of the men in the study was 72 years. Those who had at least one copy of apoE-4 had smaller brain volumes when compared to those who did not have the gene variant. DeCarli says there were not enough people in the study with two copies of the variant to assess that effect.

On average, those studied who had at least one copy of apoE-4 had a brain volume of 919.4 cubic centimeters. Those who were free of apoE-4 had an average brain volume of 949.1 cubic centimeters.

There was also a significant difference in the volume of white matter hyperintensities between the two groups. Men who did not have the gene variant had 3.3 cubic centimeters of their brains affected by silent stroke. Those who had apoE-4 had more than three times -- 10.4 cubic centimeters -- the amount of white matter hyperintensities in their brain.

Co-authors are Terry Reed, Ph.D., of the University of Indiana, Indianapolis, Ind.; Phillip A. Wolf, M.D., Boston University; Bruce L. Miller M.D., University of California at San Francisco; Gary E. Swan Ph.D.; and Dorit Carmelli Ph.D., SRI International, Menlo Park, Calif.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Gene Variant May Hasten Silent Strokes, Debilitating Stroke Or Alzheimer's." ScienceDaily. ScienceDaily, 9 February 1999. <www.sciencedaily.com/releases/1999/02/990209072819.htm>.
American Heart Association. (1999, February 9). Gene Variant May Hasten Silent Strokes, Debilitating Stroke Or Alzheimer's. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/1999/02/990209072819.htm
American Heart Association. "Gene Variant May Hasten Silent Strokes, Debilitating Stroke Or Alzheimer's." ScienceDaily. www.sciencedaily.com/releases/1999/02/990209072819.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins